Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Dexcom, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

There were no material changes to our quantitative and qualitative disclosures about market risk during the six months ended June 30, 2026. See Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, for a detailed discussion of our market risks.